Metraipolis › archive › dc_160326328616
Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42218313
- DOI
- 10.1007/s10571-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T03:09:24.377Z
- SHA-256 of the archived text
1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca- Stable URL of this page
https://metraipolis.com/documento/dc_160326328616
How to cite
Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313 — Europe PMC (en), https://europepmc.org/article/MED/42218313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_160326328616 (Metraipolis archive dc_160326328616, sha256 1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca)
BibTeX
@misc{dc160326328616,
title = {Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42218313},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_160326328616; sha256 1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42218313. Agents can read the archived copy with the MCP tool read_document.